Huntington disease: genetics and epidemiology

P M Conneally, P M Conneally

Abstract

Huntington disease (HD) is an autosomal dominant disorder in which the major gene expression occurs in the central nervous system. It is characterized by the appearance of progressive chorea and dementia, usually in adult life. One tragic aspect of the disorder, due to its late age of onset and, until recently, lack of a presymptomatic marker, is that transmission of the disease to offspring invariably occurs before symptoms develop in the parent. Although the onset of symptoms and the rate of progression may vary, the prognosis is one of relentless deterioration. The major pathological features of HD are a primary loss of cells in the caudate nucleus and putamen (striatum) but other regions of the basal ganglia, hypothalamus, and brain stem are also involved. Not only is there neuronal loss but there is also a decrease in the level of a number of neurotransmitters and associated enzymes, together with abnormalities in some receptor sites. Martin [1] described the disease as "genetically programmed cell death in the human central nervous system."

References

    1. Science. 1969 Aug 22;165(3895):762-8
    1. Br J Psychiatry. 1970 Mar;116(532):241-53
    1. Br J Psychiatry. 1970 Mar;116(532):259-70
    1. Lancet. 1970 Oct 31;2(7679):937
    1. J Med Genet. 1970 Mar;7(1):20-1
    1. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3
    1. Guys Hosp Rep. 1971;120(4):295-309
    1. N Engl J Med. 1973 Apr 19;288(16):856-7
    1. Dis Nerv Syst. 1972 May;33(5):339-44
    1. J Med Genet. 1973 Dec;10(4):333-6
    1. J Neurol Neurosurg Psychiatry. 1974 Mar;37(3):297-301
    1. Clin Genet. 1974;5(3):248-53
    1. Clin Genet. 1975 Apr;7(4):349-53
    1. Rev Med Liege. 1975 Apr 1;30(7):228-32
    1. N Engl J Med. 1975 Dec 11;293(24):1225-7
    1. Ann Hum Genet. 1976 Jan;39(3):375-9
    1. Nature. 1976 Dec 16;264(5587):654-6
    1. J R Coll Gen Pract. 1977 Jan;27(166):41-5
    1. Hum Genet. 1977 Apr 15;36(2):143-54
    1. Nature. 1977 Jun 2;267(5610):453-5
    1. Ann Neurol. 1977 May;1(5):426-30
    1. Ann Hum Genet. 1978 Oct;42(2):203-11
    1. Cytogenet Cell Genet. 1978;22(1-6):640-5
    1. Lancet. 1979 Aug 18;2(8138):346-9
    1. J Neurochem. 1979 Oct;33(4):905-11
    1. Acta Neurol Scand. 1979;60(5):272-6
    1. Annu Rev Pharmacol Toxicol. 1980;20:533-51
    1. Ann Neurol. 1980 May;7(5):406-11
    1. J Med Genet. 1980 Jun;17(3):197-202
    1. S Afr Med J. 1980 Aug 2;58(5):193-6
    1. S Afr Med J. 1980 Aug 2;58(5):201-3
    1. Am J Hum Genet. 1981 Mar;33(2):155-65
    1. Am J Hum Genet. 1981 Mar;33(2):166-74
    1. Am J Hum Genet. 1981 Mar;33(2):175-86
    1. Am J Hum Genet. 1981 Mar;33(2):187-96
    1. Am J Hum Genet. 1981 Mar;33(2):314-7
    1. Ann Hum Genet. 1980 Jul;44(Pt 1):75-9
    1. Am J Med Genet. 1982 Feb;11(2):135-41
    1. Am J Hum Genet. 1982 May;34(3):481-8
    1. Ann Hum Genet. 1981 Oct;45(Pt 4):387-96
    1. Neurology. 1982 Aug;32(8):907-9
    1. J Med Genet. 1982 Jun;19(3):161-7
    1. Nature. 1982 Sep 16;299(5880):205-6
    1. Lancet. 1983 Jan 29;1(8318):208-10
    1. Am J Med Genet. 1983 Jan;14(1):49-59
    1. J Med Genet. 1983 Feb;20(1):76-7
    1. Eur J Pharmacol. 1983 Mar 25;88(2-3):223-9
    1. Am J Hum Genet. 1983 Sep;35(5):827-37
    1. Am J Hum Genet. 1983 Sep;35(5):845-60
    1. Ann Hum Genet. 1983 Jul;47(Pt 3):205-14
    1. Nature. 1983 Nov 17-23;306(5940):234-8
    1. Proc Staff Meet Mayo Clin. 1955 Aug 10;30(16):349-57
    1. Am J Hum Genet. 1958 Jun;10(2):201-25
    1. Acta Genet Stat Med. 1959;9(1):18-32
    1. Am J Hum Genet. 1959 Jun;11(2 Part 1):107-36
    1. Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1960;201:298-312
    1. J Neurol Sci. 1964 Sep-Oct;1(5):405-20
    1. J Med Genet. 1966 Dec;3(4):298-314

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa